Gefitinib versus cetuximab in lung cancer: round one.

MLA

Minna, John D., et al. “Gefitinib versus Cetuximab in Lung Cancer: Round One.” Journal of the National Cancer Institute, vol. 97, no. 16, Aug. 2005, pp. 1168–69. EBSCOhost, https://doi.org/10.1093/jnci/dji247.

APA

Minna, J. D., Peyton, M. J., & Gazdar, A. F. (2005). Gefitinib versus cetuximab in lung cancer: round one. Journal of the National Cancer Institute, 97(16), 1168–1169. https://doi.org/10.1093/jnci/dji247

Chicago

Minna, John D, Michael J Peyton, and Adi F Gazdar. 2005. “Gefitinib versus Cetuximab in Lung Cancer: Round One.” Journal of the National Cancer Institute 97 (16): 1168–69. doi:10.1093/jnci/dji247.